14 results
POS AM
LSB
LakeShore Biopharma Co., Ltd
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
investment of $10.0 million in redeemable convertible preferred stock. Adjuvant is an investment fund formed for the charitable purpose of improving global
424B3
LSB
LakeShore Biopharma Co., Ltd
15 Aug 23
Prospectus supplement
8:00am
investment of $10.0 million in redeemable convertible preferred stock. Adjuvant is an investment fund formed for the charitable purpose of improving global
POS AM
LSB
LakeShore Biopharma Co., Ltd
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
investment of $10.0 million in redeemable convertible preferred stock. Adjuvant is an investment fund formed for the charitable purpose of improving
20-F
iur felz17c6
26 Jul 23
Annual report (foreign)
4:02pm
424B3
qvyw15u8 9qbe
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
x4wxg5u9w1t4b13zcn
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
tdkbam93
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-3.2
5j8yozso 9uw
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-99.2
lyzlurc0
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.10
ukq2mtpz5tc3q1p1s
28 Dec 22
Registration of securities (foreign)
6:58am
DRS/A
EX-10.10
ry73mh7vdj f4iu
14 Nov 22
Draft registration statement (amended)
12:00am
425
EX-10.1
a267a9ga 68sd
30 Sep 22
Business combination disclosure
9:25am
- Prev
- 1
- Next